(A chain) Gly Ile Val Glu Gln Cys Cys Thr Ser Ile Cys Ser Leu Tyr Gln Leu Glu Asn Tyr Cys Asn (B chain) Phe Val Asn Gln His Leu Cys Gly Ser His Leu Val Glu Ala Leu Tyr Leu Val Cys Gly Glu Arg Gly Phe Phe Tyr Thr Pro Lys-C14H27O (Disulfide bridge: A6-A11, A7-B7, A20-B19)
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A10 DRUGS USED IN DIABETES
A10A INSULINS AND ANALOGUES
A10AE Insulins and analogues for injection, long-acting
A10AE05 Insulin detemir
D04539 Insulin detemir (USAN/INN) <JP/US>
USP drug classification [BR:br08302]
Blood Glucose Regulators
Insulins
Insulin, Long-acting
Insulin Detemir
D04539 Insulin detemir (USAN/INN)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
24 Hormones
249 Miscellaneous
2492 Pancreatic hormones
D04539 Insulin detemir (USAN/INN); Insulin detemir (genetical recombination) (JAN)
Drug groups [BR:br08330]
Antidiabetic agent
DG01636 Insulin preparation
DG01797 Insulin analog, long-acting
D04539 Insulin detemir
Metabolizing enzyme inducer
DG01637 CYP1A2 inducer
D04539 Insulin detemir
Drug classes [BR:br08332]
Antidiabetic agent
DG01636 Insulin preparation
D04539 Insulin detemir
Target-based classification of drugs [BR:br08310]
Protein kinases
Receptor tyrosine kinases (RTK)
INSR family
INSR (CD220)
D04539 Insulin detemir (USAN/INN) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D04539
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D04539
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D04539
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D04539
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D04539
